The Risk of Colorectal Cancer in Patients with Ulcerative Colitis

Nowacki T., Brückner M., Eveslage M., Tepasse P., Pott F., Thoennissen N., Hengst K., Ross M., Bettenworth D.

Zusammenfassung

Conclusions: Despite the use of modern therapies for UC, CAC rates remain high. In our study, risk factors included disease duration while anti-inflammatory therapies reduced the risk. Effective control of the intestinal inflammation also reduced the disease burden as indicated by decreased risk of requiring colectomy, underscoring the need for sufficient surveillance and anti-inflammatory therapies.